News & Updates
Filter by Specialty:
SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
Use of an SGLT-2 inhibitor, compared with a GLP-1 receptor agonist or a DPP-4 inhibitor, helps to prevent nephrolithiasis from recurring in patients with type 2 diabetes (T2D) and pre-existing nephrolithiasis or gout, as shown in target trial emulation studies.
SGLT-2 inhibitors stop kidney stone recurrence in T2D patients with nephrolithiasis, gout
13 Nov 2024
New tool measures parent’s perceptions of obesity impact on child’s life
A parent-proxy, obesity-specific health-related quality of life (HRQoL) measure, Sizing Them Up (STU), demonstrates acceptable internal consistency, test-retest reliability, construct validity, and convergent validity in adolescents undergoing weight management treatment in Singapore, reports a study.
New tool measures parent’s perceptions of obesity impact on child’s life
09 Nov 2024
ChatGPT may aid in diabetes, MetS management, but with caveat
Artificial intelligence (AI) chatbots, such as ChatGPT, can be used by clinicians as a resource for disease management and education, but researchers of a recent study urge users to consider the “gaps” seen in managing individuals with type 2 diabetes mellitus (T2DM) and metabolic syndrome (MetS).
ChatGPT may aid in diabetes, MetS management, but with caveat
07 Nov 2024
Menopausal hormone therapy prevents relapse in women with SSD
Use of menopausal hormone therapy (MHT) can avert psychosis relapse in women with schizophrenia or schizoaffective disorder (SSD) of menopausal age, suggests a recent study.
